Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables

Objective: To assess health related quality of life of patients with congestive heart failure; to compare their quality of life with the previously characterised general population and in those with other chronic diseases; and to correlate the different aspects of quality of life with relevant somatic variables. Setting: University hospital. Patients and design: A German version of the generic quality of life measure (SF-36) containing eight dimensions was administered to 205 patients with congestive heart failure and systolic dysfunction. Cardiopulmonary evaluation included assessment of New York Heart Association (NYHA) functional class, left ventricular ejection fraction, peak oxygen uptake, and the distance covered during a standardised six minute walk test. Results: Quality of life significantly decreased with NYHA functional class (linear trend: p < 0.0001). In NYHA class III, the scores of five of the eight quality of life domains were reduced to around one third of those in the general population. The pattern of reduction was different in patients with chronic hepatitis C and major depression, and similar in patients on chronic haemodialysis. Multiple regression analysis showed that only the NYHA functional class was consistently and closely associated with all quality of life scales. The six minute walk test and peak oxygen uptake added to the explanation of the variance in only one of the eight quality of life domains (physical functioning). Left ventricular ejection fraction, duration of disease, and age showed no clear association with quality of life. Conclusions: In congestive heart failure, quality of life decreases as NYHA functional class worsens. Though NYHA functional class was the most dominant predictor among the somatic variables studied, the major determinants of reduced quality of life remain unknown.

[1]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[2]  J. Hulot,et al.  Beta‐blocker treatment in heart failure , 2001, Fundamental & clinical pharmacology.

[3]  P. Jones,et al.  The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness , 2000, Heart.

[4]  A. Steptoe,et al.  Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy , 2000, Heart.

[5]  S. Gerber,et al.  Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? , 2000, European heart journal.

[6]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.

[7]  K. Werdan,et al.  Cerebrovascular reactivity is impaired in patients with cardiac failure. , 2000, European heart journal.

[8]  L. Tavazzi,et al.  Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity. , 1999, European heart journal.

[9]  S. Svebak,et al.  Depressed Mood and Subjective Health Symptoms as Predictors of Mortality in Patients with Congestive Heart Failure: A Two-Years Follow-up Study , 1999, International journal of psychiatry in medicine.

[10]  E. Havranek,et al.  Prevalence of depression in congestive heart failure. , 1999, The American journal of cardiology.

[11]  J. Cohn Improving Outcomes in Congestive Heart Failure: Val-HeFT , 1999, Cardiology.

[12]  B. Phillips,et al.  Improving outcomes in congestive heart failure. , 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[13]  L. Abramson,et al.  Depressogenic cognitive styles: predictive validity, information processing and personality characteristics, and developmental origins. , 1999, Behaviour research and therapy.

[14]  H. Thomas,et al.  Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis , 1998, Hepatology.

[15]  W. Herzog,et al.  QUALITY OF LIFE, ANXIETY AND DEPRESSION DEPENDENT ON NYHA-CLASS IN PATIENTS WITH CHRONIC HEART FAILURE , 1998 .

[16]  Monika Bullinger,et al.  SF-36, Fragebogen zum Gesundheitszustand , 1998 .

[17]  A. Maisel,et al.  Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. , 1998, American heart journal.

[18]  Milton Packer,et al.  Safety and efficacy of carvedilol in severe heart failure , 1997 .

[19]  A. Steptoe,et al.  Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. , 1997, Heart.

[20]  S. Leeder,et al.  Burden and outcomes of hospitalisation for congestive heart failure , 1997, The Medical journal of Australia.

[21]  F. Dekker,et al.  Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  M. Bullinger [Health related quality of life and subjective health. Overview of the status of research for new evaluation criteria in medicine]. , 1997, Psychotherapie, Psychosomatik, medizinische Psychologie.

[23]  F. Dekker,et al.  Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  J. Cohn,et al.  Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. , 1997, Journal of cardiac failure.

[25]  S. Kubo Effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. , 1997, Cardiology.

[26]  C. Jenkinson,et al.  Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). , 1997, Age and ageing.

[27]  J. Wilson,et al.  Circulatory status and response to cardiac rehabilitation in patients with heart failure. , 1996, Circulation.

[28]  D. Bates,et al.  Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. , 1996, The American journal of medicine.

[29]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[30]  S. Yusuf,et al.  Effects of exercise training in patients with congestive heart failure: a critical review. , 1995, Journal of the American College of Cardiology.

[31]  G. Guyatt Measurement of health-related quality of life in heart failure. , 1993, Journal of the American College of Cardiology.

[32]  J. Cohn,et al.  Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. , 1993, The American journal of cardiology.

[33]  R. Niaura,et al.  Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. , 1993, The American journal of cardiology.

[34]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[35]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[36]  L. Stevenson,et al.  Quality of life in patients with advanced heart failure. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  M. Brodsky,et al.  Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group. , 1992, Circulation.

[38]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[39]  A. Stewart,et al.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.

[40]  G. Metalsky,et al.  Hopelessness depression: A theory-based subtype of depression. , 1989 .

[41]  William H. Rogers,et al.  Functional Status and Well-Being of Patients with Chronic Conditions , 1989 .

[42]  N. Wenger Quality of life: can it and should it be assessed in patients with heart failure? , 1989, Cardiology.

[43]  T. Rector Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire , 1987 .

[44]  G. Guyatt,et al.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.

[45]  C. Furberg,et al.  Assessment of quality of life in clinical trials of cardiovascular therapies. , 1984, The American journal of cardiology.